RHEUMATOID ARTHRITIS (RA) DECISION AID
Tool to identify informed treatment preferences of rheumatoid arthritis patients.
PREFER is a 5-year, IMI-funded, project that aims to investigate how and when patient preferences regarding the benefit/risk of drugs can be used in the medical product lifecycle. As part of the project, researchers are evaluating various research questions in clinical patient preference case studies.
One of the case studies being evaluated in PREFER is in the area of rheumatoid arthritis. The rheumatoid arthritis (treatment options) study is led by Uppsala University. To support this case study, MindBytes developed an interactive educational tool to inform patients on several aspects of the study:
- Disease context of RA.
- The concept, benefits and risks of treatments for RA, including treatment attributes and attribute levels (included in the Discrete Choice Experiment (DCE) to elicit patient preference).
Developed for Uppsala University (Sweden), as part of the IMI-PREFER project.
Tool provides interactive information on disease, treatments, benefit-risks, quality of life and the trade-offs between various available treatments.
The educational module is linked to a preference elicitation tool (DCE survey in SawTooth).